These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 7609502)

  • 21. Various approaches to evaluating the kinetics and efficacy of three antihypertensive drugs in terms of variations in blood pressure and heart rate.
    Mallion JM; Siché JP; Baguet JP; Noirclerc M; De Gaudemaris R
    Blood Press Monit; 1998 Jun; 3(3):189-194. PubMed ID: 10212353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evaluation of trough/peak ratio of indapamide 1.5 mg sustained-release form assessed by ambulatory blood pressure monitoring].
    Mallion JM; Asmar R; Ambrosioni E; MacMahon M; Coupez JM; de Cordoüe A; Barrandon S; Brault Y; Guez D; Safar M
    Arch Mal Coeur Vaiss; 1996 Sep; 89 Spec No 4():27-38. PubMed ID: 8952811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Problems in the evaluation of antihypertensive therapy using the trough/peak ratio.
    Prattichizzo FA; Galetta F; Simonetti I
    Cardiovasc Drugs Ther; 1997 Jul; 11(3):459-63. PubMed ID: 9310274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of once-daily antihypertensive therapy.
    Myers MG
    Heart Dis; 2000; 2(2):S7-12. PubMed ID: 11728257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of trough:peak ratio in the assessment of antihypertensive drug therapy.
    Myers MG
    Can J Cardiol; 1994 Nov; 10 Suppl D():17D-20D. PubMed ID: 7954034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The rationale for drug combinations in the therapy of arterial hypertension].
    Salvetti A; Virdis A; Di Venanzio L
    Ann Ital Med Int; 1993 Oct; 8 Suppl():107S-110S. PubMed ID: 8117517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of trough:peak ratio and the assessment of anti-hypertensive drug action.
    Elliott HL; Meredith PA
    J Hum Hypertens; 1995 Jun; 9(6):423-7. PubMed ID: 7473522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of the long-term treatment with losartan and captopril and of the abrupt cessation on circadian blood pressure profile].
    Gorbunov VM; Savina LV; Metelitsa VI; Deev AD
    Eksp Klin Farmakol; 2001; 64(2):45-50. PubMed ID: 11548448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [How relevant is the trough-to peak ratio?].
    Ferrari P
    Schweiz Med Wochenschr; 2000 Mar; 130(9):329-35. PubMed ID: 10746273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [New treatments in hypertension: direct renin inhibitors].
    Leibovitz E; Schiffrin EL
    Harefuah; 2008 Mar; 147(3):218-23, 278. PubMed ID: 18488863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trough to peak ratio: current status and applicability.
    Elliott HL
    J Hum Hypertens; 1998 Jan; 12(1):55-9. PubMed ID: 9482135
    [No Abstract]   [Full Text] [Related]  

  • 32. Methodological considerations in calculation of the trough: peak ratio.
    Elliott HL; Meredith PA
    J Hypertens Suppl; 1994 Nov; 12(8):S3-6; discussion S6-7. PubMed ID: 7707153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of Fourier analysis in the calculation of trough to peak ratio from ambulatory blood pressure measurements.
    Diamant M; Idema RN; Vincent HH
    J Hum Hypertens; 1998 Jan; 12(1):61-7. PubMed ID: 9482136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences between calcium antagonists: duration of action and trough to peak ratio.
    Meredith PA; Reid JL
    J Hypertens Suppl; 1993 Mar; 11(1):S21-6. PubMed ID: 8483017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trough: peak ratio and smoothness index for antihypertensive agents.
    Meredith PA
    Blood Press Monit; 1999 Oct; 4(5):257-62. PubMed ID: 10547647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Organ protection and optimal blood pressure control.
    Meredith PA
    Am J Hypertens; 1995 Oct; 8(10 Pt 2):59S-62S. PubMed ID: 8845085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methodology to determine duration of action for antihypertensive drugs.
    Lefebvre J; Poirier L; Lacourcière Y
    Ann Pharmacother; 2002 May; 36(5):874-81. PubMed ID: 11978167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ambulatory blood pressure monitoring and antihypertensive treatment.
    Mancia G; Giannattasio C; Omboni S
    Eur Heart J; 1992 Dec; 13 Suppl G():43-7. PubMed ID: 1486904
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Some problems with antihypertensive drug studies in the context of the new guidelines.
    Rose M; McMahon FG
    Am J Hypertens; 1990 Feb; 3(2):151-5. PubMed ID: 2407266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Shortcomings in the trough to peak ratio as a guide to the dose interval for antihypertensive drugs.
    Millar JA
    J Hum Hypertens; 1998 Jan; 12(1):37-44. PubMed ID: 9482132
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.